We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
AMETEK (AME) Q2 Earnings Show Electronics Instruments Strength
Read MoreHide Full Article
AMETEK’s (AME - Free Report) latest quarterly results benefited from both its segments, especially the Electronic Instruments Group (EIG). The robust portfolio of advanced analytical, test and measurement instruments for the process, aerospace, medical, research, power and industrial markets continued to drive organic growth within the segment. Positive contributions from strategic acquisitions have also been benefiting EIG for quite some time now.
Strength in EIG: Key Catalyst
In second-quarter 2023, the EIG segment generated sales of $1.135 billion (68.9% of total sales), reflecting growth of 10% year over year. The figure exhibited very strong organic growth of 8%. The reported figure also came ahead of the Zacks Consensus Estimate of $1.131 billion.
A strong demand environment across various end markets drove top-line growth within the segment. Solid momentum across aerospace and defense and ultra-precision technology businesses contributed well.
Growing sales of the company’s instrumentation, systems and sensors for applications in the aerospace market remained a positive. Strength in process and analytical instrumentation, which offers process analyzers, emission monitors, spectrometers, temperature sensors, transmitters and elemental and surface analysis instruments, remained a tailwind.
This apart, acquisitions like Navitar, Alphasense, Magnetrol, RTDS, Abaco Systems, Crank Software and NSI-MI continued to contribute well to EIG sales.
Notably, the segment generated operating margins of 27.1%, which expanded 130 basis points on a year-over-year basis. This was driven by solid execution of the operational drive.
In the second quarter, AMETEK reported revenues of $1.65 billion, up 9% year over year, which is within the management’s guidance of mid- to high-single digits sales growth. The figure topped the Zacks Consensus Estimate of $1.64 billion and exhibited organic growth of 5%.
The company’s adjusted earnings of $1.57 per share surpassed the Zacks Consensus Estimate by 3.3% and grew 14% on a year-over-year basis. The bottom line also came above the management’s guided range of $1.49-$1.51.
Shares of AME have gained 14.5% on a year-to-date basis.
Some other top-ranked stocks in the broader technology sector are Salesforce (CRM - Free Report) , AvidXchange (AVDX - Free Report) and Akamai Technologies (AKAM - Free Report) , each carrying a Zacks Rank #2.
Salesforce shares have gained 70.7% in the year-to-date period. The long-term earnings growth rate for CRM is currently projected at 19.25%.
AvidXchange shares have increased 21.1% in the year-to-date period. The long-term earnings growth rate for AVDX is currently projected at 22.90%.
Akamai shares have gained 9.5% in the year-to-date period. The long-term earnings growth rate for AKAM is currently projected at 10%.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Shutterstock
AMETEK (AME) Q2 Earnings Show Electronics Instruments Strength
AMETEK’s (AME - Free Report) latest quarterly results benefited from both its segments, especially the Electronic Instruments Group (EIG). The robust portfolio of advanced analytical, test and measurement instruments for the process, aerospace, medical, research, power and industrial markets continued to drive organic growth within the segment. Positive contributions from strategic acquisitions have also been benefiting EIG for quite some time now.
Strength in EIG: Key Catalyst
In second-quarter 2023, the EIG segment generated sales of $1.135 billion (68.9% of total sales), reflecting growth of 10% year over year. The figure exhibited very strong organic growth of 8%. The reported figure also came ahead of the Zacks Consensus Estimate of $1.131 billion.
A strong demand environment across various end markets drove top-line growth within the segment. Solid momentum across aerospace and defense and ultra-precision technology businesses contributed well.
Growing sales of the company’s instrumentation, systems and sensors for applications in the aerospace market remained a positive. Strength in process and analytical instrumentation, which offers process analyzers, emission monitors, spectrometers, temperature sensors, transmitters and elemental and surface analysis instruments, remained a tailwind.
This apart, acquisitions like Navitar, Alphasense, Magnetrol, RTDS, Abaco Systems, Crank Software and NSI-MI continued to contribute well to EIG sales.
Notably, the segment generated operating margins of 27.1%, which expanded 130 basis points on a year-over-year basis. This was driven by solid execution of the operational drive.
AMETEK, Inc. Price, Consensus and EPS Surprise
AMETEK, Inc. price-consensus-eps-surprise-chart | AMETEK, Inc. Quote
Q2 Result Highlights
In the second quarter, AMETEK reported revenues of $1.65 billion, up 9% year over year, which is within the management’s guidance of mid- to high-single digits sales growth. The figure topped the Zacks Consensus Estimate of $1.64 billion and exhibited organic growth of 5%.
The company’s adjusted earnings of $1.57 per share surpassed the Zacks Consensus Estimate by 3.3% and grew 14% on a year-over-year basis. The bottom line also came above the management’s guided range of $1.49-$1.51.
Zacks Rank & Other Stocks to Consider
AMETEK currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Shares of AME have gained 14.5% on a year-to-date basis.
Some other top-ranked stocks in the broader technology sector are Salesforce (CRM - Free Report) , AvidXchange (AVDX - Free Report) and Akamai Technologies (AKAM - Free Report) , each carrying a Zacks Rank #2.
Salesforce shares have gained 70.7% in the year-to-date period. The long-term earnings growth rate for CRM is currently projected at 19.25%.
AvidXchange shares have increased 21.1% in the year-to-date period. The long-term earnings growth rate for AVDX is currently projected at 22.90%.
Akamai shares have gained 9.5% in the year-to-date period. The long-term earnings growth rate for AKAM is currently projected at 10%.